Clinical Trial Update: Targeted Prostate Cancer Screening in Men With BRCA1/2 Mutations [NA]

View source ↗

Summary

Clinical trial update on targeted prostate cancer screening in men with BRCA1/2 mutations; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Prostate Cancer, Hereditary Prostate Cancer | NA | Status: COMPLETED